Article
An appraisal of genetic testing for prostate cancer susceptibility
22 Jun 2022
Abstract excerpt
Most criteria for genetic testing for prostate cancer susceptibility require a prior diagnosis of prostate cancer, in particular cases with metastatic disease are selected. Advances in the field are expected to improve outcomes through tailored treatments for men with advanced prostate cancer with germline pathogenic variants, although these are not currently offered in the curative setting. A better...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
